The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
Hydroxychloroquine (HCH) is included in guidelines for treatment of novel coronavirus infection (COVID-19). Data on increased risk of cardiovascular complications when using it have been published. Aim. To evaluate the safety and tolerability of HCH and azithromycine (AZM) combination for the treatm...
Saved in:
| Main Authors: | Yu. N. Belenkov, I. V. Menshikova, I. S. Ilgisonis, Yu. I. Naimann, Yu. V. Pak, I. R. Kolosova, A. S. Rakovskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2020-12-01
|
| Series: | Сеченовский вестник |
| Subjects: | |
| Online Access: | https://www.sechenovmedj.com/jour/article/view/239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
by: Mondher Toumi, et al.
Published: (2020-01-01) -
Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020-07-01) -
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
by: Saja H. Almazrou, et al.
Published: (2020-12-01) -
Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01) -
CHLOROQUINE AND HYDROXYCHLOROQUINE ARE AVAILABLE TREATMENT OPTIONS TO FIGHT WITH COVID-19
by: Shadia S. Alhamd, et al.
Published: (2020-11-01)